U.S Physical Therapy PE Ratio 2012-2026 | USPH
Current and historical p/e ratio for U.S Physical Therapy (USPH) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. U.S Physical Therapy PE ratio as of September 15, 2026 is 32.19.
| U.S Physical Therapy PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-16 | 83.39 | 490.53 | |
| 2026-06-30 | 68.28 | $0.17 | 401.62 |
| 2026-03-31 | 73.97 | $0.50 | 147.95 |
| 2025-12-31 | 76.61 | $1.42 | 53.95 |
| 2025-09-30 | 82.81 | $2.38 | 34.80 |
| 2025-06-30 | 75.83 | $2.29 | 33.11 |
| 2025-03-31 | 69.74 | $2.18 | 31.99 |
| 2024-12-31 | 85.00 | $1.84 | 46.20 |
| 2024-09-30 | 80.70 | $0.87 | 92.76 |
| 2024-06-30 | 87.66 | $0.99 | 88.54 |
| 2024-03-31 | 106.61 | $1.16 | 91.90 |
| 2023-12-31 | 87.60 | $1.28 | 68.44 |
| 2023-09-30 | 85.85 | $1.72 | 49.91 |
| 2023-06-30 | 113.13 | $1.93 | 58.62 |
| 2023-03-31 | 90.89 | $2.16 | 42.08 |
| 2022-12-31 | 74.89 | $2.25 | 33.28 |
| 2022-09-30 | 69.92 | $2.98 | 23.46 |
| 2022-06-30 | 99.96 | $2.92 | 34.23 |
| 2022-03-31 | 90.67 | $2.87 | 31.59 |
| 2021-12-31 | 86.74 | $2.41 | 35.99 |
| 2021-09-30 | 100.04 | $2.37 | 42.21 |
| 2021-06-30 | 104.44 | $2.32 | 45.02 |
| 2021-03-31 | 93.54 | $2.49 | 37.57 |
| 2020-12-31 | 107.74 | $2.48 | 43.44 |
| 2020-09-30 | 77.84 | $2.35 | 33.12 |
| 2020-06-30 | 72.59 | $2.40 | 30.24 |
| 2020-03-31 | 61.82 | $2.26 | 27.35 |
| 2019-12-31 | 102.10 | $2.45 | 41.67 |
| 2019-09-30 | 116.26 | $2.33 | 49.90 |
| 2019-06-30 | 108.91 | $1.80 | 60.50 |
| 2019-03-31 | 93.11 | $1.43 | 65.11 |
| 2018-12-31 | 90.50 | $1.31 | 69.09 |
| 2018-09-30 | 104.66 | $1.46 | 71.69 |
| 2018-06-30 | 84.55 | $1.74 | 48.59 |
| 2018-03-31 | 71.42 | $1.65 | 43.29 |
| 2017-12-31 | 63.25 | $1.76 | 35.94 |
| 2017-09-30 | 53.67 | $1.60 | 33.55 |
| 2017-06-30 | 52.58 | $1.57 | 33.49 |
| 2017-03-31 | 56.50 | $1.66 | 34.04 |
| 2016-12-31 | 60.74 | $1.64 | 37.04 |
| 2016-09-30 | 54.10 | $1.59 | 34.03 |
| 2016-06-30 | 51.81 | $1.68 | 30.84 |
| 2016-03-31 | 42.66 | $1.68 | 25.39 |
| 2015-12-31 | 45.89 | $1.66 | 27.65 |
| 2015-09-30 | 38.26 | $1.64 | 23.33 |
| 2015-06-30 | 46.54 | $1.60 | 29.09 |
| 2015-03-31 | 40.25 | $1.64 | 24.54 |
| 2014-12-31 | 35.44 | $1.57 | 22.57 |
| 2014-09-30 | 29.80 | $1.53 | 19.48 |
| 2014-06-30 | 28.70 | $1.12 | 25.62 |
| 2014-03-31 | 28.90 | $1.01 | 28.61 |
| 2013-12-31 | 29.37 | $1.05 | 27.97 |
| 2013-09-30 | 25.80 | $1.08 | 23.89 |
| 2013-06-30 | 22.87 | $1.44 | 15.88 |
| 2013-03-31 | 22.13 | $1.44 | 15.37 |
| 2012-12-31 | 22.60 | $1.51 | 14.97 |
| 2012-09-30 | 22.26 | $1.86 | 11.97 |
| 2012-06-30 | 20.42 | $1.82 | 11.22 |
| 2012-03-31 | 18.44 | $1.82 | 10.13 |
| 2011-12-31 | 15.67 | $1.75 | 8.96 |
| 2011-09-30 | 14.69 | $1.40 | 10.49 |
| 2011-06-30 | 19.53 | $1.39 | 14.05 |
| 2011-03-31 | 17.59 | $1.36 | 12.93 |
| 2010-12-31 | 15.54 | $1.32 | 11.77 |
| 2010-09-30 | 13.11 | $1.18 | 11.11 |
| 2010-06-30 | 13.24 | $1.11 | 11.92 |
| 2010-03-31 | 13.64 | $1.04 | 13.12 |
| 2009-12-31 | 13.28 | $1.00 | 13.28 |
| 2009-09-30 | 11.82 | $0.98 | 12.06 |
| 2009-06-30 | 11.57 | $0.93 | 12.44 |
| 2009-03-31 | 7.59 | $0.86 | 8.83 |
| 2008-12-31 | 10.45 | $0.83 | 12.59 |
| 2008-09-30 | 13.61 | $0.86 | 15.83 |
| 2008-06-30 | 12.87 | $0.83 | 15.50 |
| 2008-03-31 | 11.31 | $0.79 | 14.31 |
| 2007-12-31 | 11.27 | $0.75 | 15.02 |
| 2007-09-30 | 11.61 | $0.73 | 15.90 |
| 2007-06-30 | 10.56 | $0.60 | 17.60 |
| 2007-03-31 | 10.92 | $0.58 | 18.82 |
| 2006-12-31 | 9.61 | $0.54 | 17.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.220B | $0.781B |
| U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |